[ad_1]
Article content material
BURNABY, British Columbia, Oct. 03, 2021 (GLOBE NEWSWIRE) — Xenon Prescribed drugs Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical firm, right this moment introduced that Xenon administration will host a convention name and webcast to debate topline outcomes from the XEN1101 Part 2b “X-TOLE” scientific trial on Monday, October 4, 2021 at 7:30 am Japanese Time.
- A convention name and webcast with slides shall be broadcast reside on the Investors section of the Xenon website. To take part within the name, please dial (855) 779-9075, or (631) 485-4866 for worldwide callers, and supply convention ID quantity 4481713.
Article content material
The above listed dates and occasions are topic to alter. When accessible, webcasts shall be posted for replay following the occasion.
About Xenon Prescribed drugs Inc.
We’re a scientific stage biopharmaceutical firm dedicated to growing modern therapeutics to enhance the lives of sufferers with neurological problems. We’re advancing a novel product pipeline of neurology therapies to handle areas of excessive unmet medical want, with a deal with epilepsy. For extra info, please go to www.xenon-pharma.com.
“Xenon” and the Xenon emblem are registered logos or logos of Xenon Prescribed drugs Inc. in numerous jurisdictions. All different logos belong to their respective proprietor.
Media / Investor Contacts:
Maria McClean / Jodi Regts
Xenon Prescribed drugs Inc.
Cellphone: 604-484-3353 / 778-999-5634
E-mail: investors@xenon-pharma.com
[ad_2]
Source